search
Back to results

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease (CAD-AAA)

Primary Purpose

Abdominal Aortic Aneurysm

Status
Completed
Phase
Not Applicable
Locations
Finland
Study Type
Interventional
Intervention
ultrasound of aorta
Sponsored by
North Karelia Central Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Abdominal Aortic Aneurysm

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)Male

Inclusion Criteria:

  • Male patients with coronary artery disease

Exclusion Criteria:

  • Patient's denial to participate
  • Female Gender
  • Already diagnosed or treated abdominal aortic aneurysm

Sites / Locations

  • North Carelia Central Hospital

Arms of the Study

Arm 1

Arm Type

Other

Arm Label

ultrasound of aorta

Arm Description

Outcomes

Primary Outcome Measures

Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound

Secondary Outcome Measures

Full Information

First Posted
July 9, 2013
Last Updated
December 15, 2014
Sponsor
North Karelia Central Hospital
Collaborators
Kuopio University Hospital, Tampere University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT01897623
Brief Title
Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
Acronym
CAD-AAA
Official Title
Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease
Study Type
Interventional

2. Study Status

Record Verification Date
December 2014
Overall Recruitment Status
Completed
Study Start Date
July 2013 (undefined)
Primary Completion Date
October 2014 (Actual)
Study Completion Date
October 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
North Karelia Central Hospital
Collaborators
Kuopio University Hospital, Tampere University Hospital

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the prevalence of abdominal aortic aneurysms (AAA) among male patients with coronary artery disease (CAD) verified in coronary angiography. Ethiology of AAA is known to be common with atherosclerotic arterial diseases (coronary artery disease, peripheral artery disease and carotid artery disease), so the hypothesis is that AAA should be more common among these CAD patients, thus making screening of these patients (for AAA) more cost-efficient. Study will be carried out as a multi-center prospective screening study. Data will be collected in North Karelia Central Hospital, Kuopio University Hospital and Tampere University Hospital. Data consists of 200 consecutive coronary angiography patients in each hospital, resulting in 600 patients in total. All male patients with diagnosed CAD will be recruited for the study and screened for AAA with ultrasound. Nevertheless, patients with previously known AAA will be excluded from the study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Abdominal Aortic Aneurysm

7. Study Design

Primary Purpose
Screening
Study Phase
Not Applicable

8. Arms, Groups, and Interventions

Arm Title
ultrasound of aorta
Arm Type
Other
Intervention Type
Other
Intervention Name(s)
ultrasound of aorta
Primary Outcome Measure Information:
Title
Maximum diameter (mm) of abdominal aorta (outer-to-outer wall) in ultrasound
Time Frame
upon screening

10. Eligibility

Sex
Male
Eligibility Criteria
Inclusion Criteria: Male patients with coronary artery disease Exclusion Criteria: Patient's denial to participate Female Gender Already diagnosed or treated abdominal aortic aneurysm
Facility Information:
Facility Name
North Carelia Central Hospital
City
Joensuu
State/Province
Pohjois-Karjala
ZIP/Postal Code
80200
Country
Finland

12. IPD Sharing Statement

Learn more about this trial

Prevalence and Screening of Abdominal Aortic Aneurysms Among Men With Coronary Artery Disease

We'll reach out to this number within 24 hrs